Transcode Therapeutics

RNAZNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$4.192 M

$3.96 -7.26%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$34.7M

Loss-making

Shares outstanding

916,968

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#477CapstoneCAPS$4.29M
#478Propanc BiopharmaPPCB$4.20M
#479Transcode TherapeuticsRNAZ$4.19M
#480PMGCELAB$4.16M
#481InMed PharmaceuticalsINM$4.12M

Where these numbers come from

Share counts and financials for Transcode Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.